Get startedLog in
    Picture of ExpreS2ion Biotech Holding AB logo

    EXPRS2 — ExpreS2ion Biotech Holding AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Expres2ion Announces cVLP COVID-19 Vaccine Shows Strong Virus Neutralization Properties In Animal Proof-Of-Concept Data

    Picture of ExpreS2ion Biotech Holding AB logoExpreS2ion Biotech Holding AB
    09/06/2020 19:04
    June 9 (Reuters) - ExpreS2ion Biotech Holding AB
 EXPRS2.ST :
    * EXPRES2ION ANNOUNCES THAT THE CVLP COVID-19 VACCINE SHOWS
STRONG
VIRUS NEUTRALIZATION PROPERTIES IN ANIMAL PROOF-OF-CONCEPT DATA
    * ANIMAL DATA FROM TESTS SHOW MANY-FOLD INCREASE IN
IMMUNOGENICITY
AND VIRUS NEUTRALIZATION COMPARED TO A SUB-UNIT VACCINE CONTROL

Source text for Eikon:  ID:nWkr5fWCkj 
Further company coverage:  EXPRS2.ST 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on ExpreS2ion Biotech Holding AB

    See all news